Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
Clinical trial NCT05917561 · UNKNOWN
Trial details
- NCT number
- NCT05917561
- Sponsor
- University Hospital, Bordeaux
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-15
- Primary completion
- 2026-05-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.